Phospholipase C Zeta in Human Spermatozoa: A Systematic Review on Current Development and Clinical Application
Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10045/140410
Título: | Phospholipase C Zeta in Human Spermatozoa: A Systematic Review on Current Development and Clinical Application |
---|---|
Autor/es: | Parrella, Alessandra | Medrano, María Llanos | Aizpurua, Jon | Gómez-Torres, María José |
Grupo/s de investigación o GITE: | Grupo de Inmunología, Biología Celular y del Desarrollo |
Centro, Departamento o Servicio: | Universidad de Alicante. Departamento de Biotecnología |
Palabras clave: | PLCζ | PLCZ1 | Human | Human spermatozoa | Human oocytes | Human infertility | Human oocyte activation |
Fecha de publicación: | 22-ene-2024 |
Editor: | MDPI |
Cita bibliográfica: | International Journal of Molecular Sciences. 2024, 25(2): 1344. https://doi.org/10.3390/ijms25021344 |
Resumen: | During fertilization, the fusion of the spermatozoa with the oocytes causes the release of calcium from the oocyte endoplasmatic reticulum. This, in turn, triggers a series of calcium ion (Ca2+) oscillations, a process known as oocyte activation. The sperm-specific factor responsible for oocyte activation is phospholipase C zeta (PLCζ). Men undergoing intracytoplasmic sperm injection (ICSI) with their spermatozoa lacking PLCζ are incapable of generating Ca2+ oscillation, leading to fertilization failure. The immunofluorescence assay is the most used technique to assess the expression and localization of PLCζ and to diagnose patients with reduced/absent ability to activate the oocytes. In these patients, the use of assisted oocyte activation (AOA) technique can help to yield successful ICSI results and shorten the time of pregnancy. However, the production of a stable PLCζ recombinant protein represents a new powerful therapeutic approach to treating individuals with this condition. We aim to conduct a systematic review focusing on the expression, level, and localization of PLCζ, discussing the novel genetic mutation associated with its impairment. In addition, we highlight the benefits of AOA, looking at new and less invasive methods to diagnose and treat cases with PLCζ dysfunction. |
Patrocinador/es: | This research was funded by the Cátedra Human Fertility (A-GE-Cátedra Human Fertility 35.90.6Q..00.01) and Departamento de Biotecnología of the Universidad de Alicante (VIGROB-186). |
URI: | http://hdl.handle.net/10045/140410 |
ISSN: | 1422-0067 |
DOI: | 10.3390/ijms25021344 |
Idioma: | eng |
Tipo: | info:eu-repo/semantics/article |
Derechos: | © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
Revisión científica: | si |
Versión del editor: | https://doi.org/10.3390/ijms25021344 |
Aparece en las colecciones: | INV - Grupo de Inmunología - Artículos de Revistas |
Archivos en este ítem:
Archivo | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Parrella_etal_2024_IntJMolSci.pdf | 1,21 MB | Adobe PDF | Abrir Vista previa | |
Todos los documentos en RUA están protegidos por derechos de autor. Algunos derechos reservados.